Some studies have indicated that OTSCC is biologically distinct from other oral cancer subsites and is associated with the upregulation and downregulation of specific molecular markers, such as p16, p21, p53, Ki-67, VEGFs, and cyclin D1 (16, 31, 32). This evidence concerns the gene CCND1 and lip and oral cavity carcinoma.